Send me a link:

*Text messaging rates may apply.

 Dow Down1.23% Nasdaq Down1.64%

Genomic Health Inc. (GHDX)

-NasdaqGS
25.83 Down 0.52(1.97%) 1:09PM EDT - Nasdaq Real Time Price
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 31, 2014Dec 31, 2013Sep 30, 2013Jun 30, 2013
Total Revenue 67,002   68,819   65,991   63,691  
Cost of Revenue12,055  10,815  10,782  10,757  
Gross Profit 54,947   58,004   55,209   52,934  
Operating Expenses
Research Development14,681  24,144  14,726  13,800  
Selling General and Administrative47,460  42,355  40,020  42,045  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (7,194) (8,495) 463   (2,911)
Income from Continuing Operations
Total Other Income/Expenses Net(176)(751)141  (28)
Earnings Before Interest And Taxes(7,370)(9,246)604  (2,939)
Interest Expense -   -   -   -  
Income Before Tax(7,370)(9,246)604  (2,939)
Income Tax Expense75  123  115  55  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(7,445)(9,369)489  (2,994)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (7,445) (9,369) 489   (2,994)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (7,445) (9,369) 489   (2,994)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.